Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosis

Leuk Lymphoma. 2020 Oct;61(10):2533-2535. doi: 10.1080/10428194.2020.1768387. Epub 2020 May 25.

Authors

Rudolf Benz¹, Kathrin Zimmermann², Markus Rechsteiner³, Stefan Balabanov², Markus G Manz², Corinne C Widmer²

Affiliations

¹ Division of Hematology and Oncology, Kantonsspital Muensterlingen, Muensterlingen, Switzerland.
² Department of Medical Oncology and Hematology, University Hospital of Zurich, Zurich, Switzerland.
³ Deparment of Pathology, University Hospital of Zurich, Zurich, Switzerland.

PMID: 32449412
DOI: 10.1080/10428194.2020.1768387

No abstract available

Publication types

Letter

MeSH terms

Humans
Interferons
Myelodysplastic Syndromes*
Polyethylene Glycols
Thrombocytosis* / drug therapy

Substances

Polyethylene Glycols
Interferons